-
Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2340 in its research report dated August 06, 2025.
-
Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 1840 in its research report dated February 03, 2025.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 2240 in its research report dated March 20, 2024.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 2240 in its research report dated February 14, 2024.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1920 in its research report dated November 06, 2023.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1560 in its research report dated August 07, 2023.
-
YES Securities is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated January 23, 2023.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1700 in its research report dated January 23, 2023.
-
Sharekhan recommended Hold rating on Gland Pharma with a target price of Rs 1689 in its research report dated December 29, 2022.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated November 30, 2022.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated October 27, 2022.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3080 in its research report dated July 20, 2022.
-
Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3700 in its research report dated June 25, 2022.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 3770 in its research report dated May 20, 2022.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 4040 in its research report dated April 19, 2022.
-
We are entering increasing interest rate scenario. Liquidity is drying which simply means institutional fund flows would be much more selective and sensitive to quality aspect
-
Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4240 in its research report dated January 22, 2022.
-
Emkay Global Financial is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 5000 in its research report dated November 29, 2021.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4400 in its research report dated November 26, 2021.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4400 in its research report dated September 29, 2021.
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4400 in its research report dated July 20, 2021.
-
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 4460 in its research report dated July 22, 2021.
-
While the US market is still expected to clock 18-20 per cent growth for Gland Pharma in FY22, the company’s foray into non-US markets would accelerate growth in the medium term
-
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4100 in its research report dated July 05, 2021.
-
Even after the contract with Sputnik V, it will have idle capacity available to pursue similar opportunities, including that of mRNA- platform-based ones.
